Background Report: Cost-effectiveness of Injecting Drug User Interventions to Prevent HIV in Nepal. Alban A and Manuel C (2007)

Background Report: Cost-effectiveness of Injecting Drug User Interventions to Prevent HIV in Nepal. Alban A and Manuel C (2007) This paper has two objectives. The first is to examine the robustness of two different epidemiological models; these models were used to determine the impact of IDU interventions in Nepal when interventions are scaled-up to reach 60% of IDUs, as recommended by UNAIDS. The second objective is to disseminate the outcome of two cost- effectiveness analyses of IDU interventions in Nepal. These analyses used identical data sets to determine the cost-effectiveness ratios under various scenarios of intervention coverage.

Download this publication

Modelling the Impact and Cost-effectiveness of the HIV Intervention Programme amongst Commercial Sex Workers in Ahmedabad, Gujarat, India. Fung IC, Guinness L, Vickerman P, et al (2007)

Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India. Fung IC, Guinness L, Vickerman P, et al (2007) Ahmedabad is an industrial city in Gujarat, India. In 2003, the HIV prevalence among commercial sex workers (CSWs) in Ahmedabad reached 13.0%. In response, the Jyoti Sangh HIV prevention programme for CSWs was initiated, which involves outreach, peer education, condom distribution, and free STD clinics. Two surveys were performed among CSWs in 1999 and 2003. This study estimates the cost-effectiveness of the Jyoti Sangh HIV prevention programme.

Download this publication

Technical Annex for a Proposed Grant for a HIV/AIDS Prevention Project: Afghanistan. World Bank (2007)

Technical Annex for a Proposed Grant in the Amount of SDR 6.60 Million (US$lO.O Million Equivalent) to the Islamic Republic of Afghanistan for a HIV/AIDS Prevention Project. World Bank (2007) The project will contribute to the national development goals of the Interim Afghanistan National Development Strategy (I-ANDs) o f maintaining Human Immunodeficiency Virus (HIV) prevalence below 0.5 percent in the general population and below 5 percent among vulnerable groups at high risk of infection.

Download this publication

Financing the Response to AIDS: 2006 Report on the Global AIDS Epidemic. UNAIDS (2006)

Financing the Response to AIDS: 2006 Report on the Global AIDS Epidemic. UNAIDS (2006) From UNAIDS’ launch in 1996 until 2005, available annual funding for the response to AIDS in low- and middle-income countries increased 28-fold, from US$ 300 million to US$ 8.3 billion. Existing pledges, commitments and trends suggest the rate of increase may be declining and that available funds will be US$ 8.9 billion in 2006 and US$ 10 billion in 2007.

Download this publication

Asia Pacific Regional Report on National AIDS Spending Assessment 2000-2004 (Draft). Tangcharoensathien V, Chokchaicharn H, Tisayaticom K, et al (2006)

Asia Pacific Regional Report on National AIDS Spending Assessment 2000-2004 (Draft). Tangcharoensathien V, Chokchaicharn H, Tisayaticom K, et al (2006)

Tracking how much resources were spent on HIV/AIDS as well as forecasting resource needs for scaling up responses are important inputs for effective national and global responses to the AIDS pandemic. Efficient allocation of international financial assistance and national resources for HIV/AIDS should be guided by transparent information on sources and uses of funds. The lack of timely, accurate information about spending represents a key constraint for policy decision on effective use of limited resources in developing countries.

The needs to further improve data systems are clear. At present, there has been limited success in establishing resource tracking system and a comprehensive information regarding where those funds came from and how they were spent. As a result, policy makers are unlikely to be able to effectively mobilize additional resources and allocate them toward the populations and types of services that are vital to confront the HIV/AIDS epidemic.



Download this publication

Country Report on National AIDS Spending Assessment (NASA) 2000-2004 in the Philippines. National Epidemiology Center Philippines (2005)

Country Report on National AIDS Spending Assessment (NASA) 2000-2004 in the Philippines. National Epidemiology Center Philippines (2005) The HIV/AIDS situation in the country can be described as hidden and growing. Based on the HIV/AIDS Registry of the National Epidemiology Center (NEC) of the Department of Health (DOH), the cumulative number of HIV/Ab seropositive cases has reached 2,373 since 1984. Epidemiologists and experts, however, estimate that the actual number of HIV cases is around 10,000. Despite the increasing number of cases, the prevalence rate remains consistently below one percent.

Download this publication

Macroeconomic Impact of HIV/AIDS in the Asian and Pacific Region. Tandon, A (2005)

Macroeconomic Impact of HIV/AIDS in the Asian and Pacific Region. Tandon, A (2005) Widespread prevalence of diseases such as Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome or HIV/AIDS, malaria, and tuberculosis are a significant constraint to development in low- and middle-income countries. The impact of HIV/AIDS has been especially devastating in sub-Saharan Africa where some countries are now seeing declines in life expectancy of up to 20 years as a result of the disease taking on pandemic proportions in the continent. Globally, HIV/AIDS is now the leading cause of adult mortality (WHO 2004). In 2004, an estimated 4.9 million deaths worldwide were attributable to HIV/AIDS (UNAIDS and WHO 2004). Given an average lag of 10 years between infection and death, the morbidity effects for an estimated 39.4 million people now living with HIV/AIDS are also substantial.

Download this publication

Country Report on National AIDS Spending Assessment (NASA) Year 2000-2004 in Lao PDR. Ministry of Health Department of Hygiene and Epidemiology Center for HIV/AIDS/STI. (2005)

immage

The National AIDS Spending Assessment aims to assess the situation of the actual National expenditures on HIV/AIDS activities over the last five years (2000-2004) from different institutions. The total AIDS expenditure over the past five years is estimated at Lao Kip 148.62 billion (USD 14.85 million). The expenditure trend has shown the steadily increase steadily every year from 2.1 million in 2000 to 4.99 million in 2004. There were two sources of National AIDS Spending, from the government (in kind see table 2), and from external assistant. Remarkably, a large spending of AIDS came from external sources of 98.83 percent to 99.83 percent.

 

Download Publication

Resource Needs for an Expanded Response to AIDS in Low- and Middle-Income Countries. UNAIDS (2005)

Resource Needs for an Expanded Response to AIDS in Low- and Middle-Income Countries. UNAIDS (2006) In the four months since the High-Level Meeting on “The Global Response to AIDS: Making the Money Work – The Three Ones in Action” on March 9th 2005, the estimates for the AIDS resource needs have been refined and updated. The revisions are based on newly available information and invaluable input from the recently formed Resource Needs Steering Committee and the Resource Needs Technical Working Group.

Download this publication

Economic and Social Progress in Jeopardy: HIV/AIDS in the Asian and Pacific Region. ESCAP (2003)

Economic and Social Progress in Jeopardy: HIV/AIDS in the Asian and Pacific Region. ESCAP (2003) At its first opportunity following the United Nations General Assembly special session on HIV/AIDS, the Commission, at its fifty-eighth session in April 2002, adopted as its theme topic for the fifty-ninth session “Integrating economic and social concerns, especially HIV/AIDS, in meeting the needs of the region”.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Monitoring_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_What_New_in_Treatment_Monitoring_Viral_Load_and_CD4_Testing_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_IBBS_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Pakistan_Mapping_Key_Populations_2015-16.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_Global_AIDS_Update_2017_Data_2017_en.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_2017_Global_AIDS_Monitoring_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal-IBBS-FIDU-Kathmandu-valley-RI-2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/2015_Size_Estimation_of_Key_Affected_Populations_in_Philippines.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Assessment_of_Decentralization_of_ART_in_MMR_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-2016-prevention-gap-report_en.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Implementing_comprehensive_HIV_and_STI_programmes_with_transgender_people_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Philippines_2015_IHBSS_Fact_Sheets_Nov2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)